Results from studies involving 12 molecules in Amgen’s oncology portfolio will be presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago June 1-5, 2012.

Abstracts are available on the ASCO website at http://abstract.asco.org/ and updated data will be presented at the meeting.

If you are at ASCO, stop by Amgen’s booth #7042 to learn more about Amgen Oncology.

Follow Amgen on Twitter at http://twitter.com/amgen to receive news updates during ASCO.